SCHEMBL26907652

SCHEMBL26907652

CC1(C)OB(c2ccc3nc(NC(=O)O)cn3c2)OC1(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP3K5 Q99683 8/20 0.42
PIK3CA P42336 1/20 0.38
PIK3CG P48736 1/20 0.38
F2 P00734 1/20 0.38
F11 P03951 1/20 0.38
PRSS1 P07477 1/20 0.38
PRSS2 P07478 1/20 0.38
PRSS3 P35030 1/20 0.38
TGFBR1 P36897 1/20 0.37
LRRK2 Q5S007 3/20 0.36
HIF1A Q16665 1/20 0.36
MAPK13 O15264 1/20 0.36
BRAF P15056 1/20 0.36
KDR P35968 1/20 0.36
MAPK12 P53778 1/20 0.36
MAPK11 Q15759 1/20 0.36
MAPK14 Q16539 1/20 0.36
KDM4E B2RXH2 1/20 0.36
NPC1 O15118 1/20 0.36
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3133492 0.90 PIK3CA (0.47) MAP3K5PIK3CAPIK3CGTGFBR1MAPK13
SCHEMBL24286056 0.86 F2 (0.42) MAP3K5PIK3CAPIK3CGF2F11
SCHEMBL17065966 0.86 LRRK2 (0.49) LRRK2KDR
SCHEMBL31204283 0.84 OTUD7B (0.42) MAP3K5PIK3CAPIK3CGF2F11
SCHEMBL29770756 0.84 AAK1 (0.42) MAP3K5PIK3CAPIK3CG
SCHEMBL22363009 0.82 LRRK2 (0.57) LRRK2
SCHEMBL1734165 0.81 PTGS1 (0.46) F2F11PRSS1PRSS2PRSS3
SCHEMBL31204322 0.81 OTUD7B (0.40) MAP3K5PIK3CAPIK3CGLRRK2
SCHEMBL14658714 0.78 LPL (0.40) F11LPLLIPGCA1CA2
SCHEMBL3770025 0.78 NPC1 (0.56) KDRKDM4ENPC1ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240174662-A1 SMALL MOLECULE INHIBITORS OF SALT INDUCIBLE KINASES CILAG AG (CH) 2024-05-30 US disclosed
EP-4284802-A1 SMALL MOLECULE INHIBITORS OF SALT INDUCIBLE KINASES Janssen Biotech, Inc. (US) 2023-12-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240174662-A1 SMALL MOLECULE INHIBITORS OF SALT INDUCIBLE KINASES SIK2, SIK1, SGK2 MAP3K5 21/4885PIK3CA 470/4885PIK3CG 520/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.